0000899243-21-005096.txt : 20210205 0000899243-21-005096.hdr.sgml : 20210205 20210205184600 ACCESSION NUMBER: 0000899243-21-005096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210203 FILED AS OF DATE: 20210205 DATE AS OF CHANGE: 20210205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bodenrader Mark CENTRAL INDEX KEY: 0001830371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39311 FILM NUMBER: 21597804 MAIL ADDRESS: STREET 1: C/O CEREVEL THERAPEUTICS HOLDINGS INC. STREET 2: 131 DARTMOUTH STREET SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001805387 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 844-304-2048 MAIL ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II DATE OF NAME CHANGE: 20200303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-03 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001830371 Bodenrader Mark C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 0 1 0 0 See Remarks Stock Option (Right to Buy) 12.70 2021-02-03 4 A 0 90000 0.00 A 2031-02-03 Common Stock 90000 90000 D 25% of this option shall vest and become exercisable on February 3, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Vice President, Finance and Chief Accounting Officer /s/ Mark Bodenrader 2021-02-05